First Horizon Advisors, Inc. Boston Scientific Corp Transaction History

First Horizon Advisors, Inc.

$3.58 Billion
Q3 2024

A detailed history of First Horizon Advisors, Inc. transactions in Boston Scientific Corp stock. As of the latest transaction made, First Horizon Advisors, Inc. holds 6,425 shares of BSX stock, worth $583,068. This represents 0.02% of its overall portfolio holdings.

Number of Shares

6,425

Previous 6,384 0.64%

Holding current value

$583,068

Previous $491,000 9.57%

% of portfolio

0.02%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$72.96 - $84.0 $2,991 - $3,444	41 Added 0.64%	6,425 $538,000
Q2 2024 Jul 19, 2024	BUY	$67.33 - $77.71 $16,697 - $19,272	248 Added 4.04%	6,384 $491,000
Q1 2024 Apr 26, 2024	BUY	$57.6 - $68.62 $67,161 - $80,010	1,166 Added 23.46%	6,136 $420,000
Q4 2023 Feb 06, 2024	BUY	$48.64 - $57.81 $17,315 - $20,580	356 Added 7.72%	4,970 $287,000
Q3 2023 Oct 27, 2023	BUY	$50.19 - $54.68 $7,679 - $8,366	153 Added 3.43%	4,614 $243,000
Q2 2023 Aug 03, 2023	BUY	$49.72 - $54.64 $12,827 - $14,097	258 Added 6.14%	4,461 $241,000
Q1 2023 May 15, 2023	SELL	$45.09 - $50.03 $24,213 - $26,866	-537 Reduced 11.33%	4,203 $210,000
Q4 2022 Feb 10, 2023	BUY	$39.56 - $47.22 $4,786 - $5,713	121 Added 2.62%	4,740 $219,000
Q3 2022 Nov 09, 2022	BUY	$36.71 - $109.66 $16,592 - $49,566	452 Added 10.85%	4,619 $178,000
Q2 2022 Aug 02, 2022	BUY	$35.24 - $47.1 $16,280 - $21,760	462 Added 12.47%	4,167 $155,000
Q1 2022 May 10, 2022	BUY	$40.9 - $45.1 $21,104 - $23,271	516 Added 16.18%	3,705 $164,000
Q4 2021 Feb 09, 2022	SELL	$38.07 - $44.87 $571 - $673	-15 Reduced 0.47%	3,189 $135,000
Q3 2021 Nov 15, 2021	SELL	$41.23 - $45.88 $783 - $871	-19 Reduced 0.59%	3,204 $139,000
Q3 2021 Nov 09, 2021	BUY	$41.23 - $45.88 $25,727 - $28,629	624 Added 24.01%	3,223 $139,000
Q2 2021 Aug 09, 2021	SELL	$38.58 - $44.24 $3,086 - $3,539	-80 Reduced 2.99%	2,599 $111,000
Q1 2021 May 11, 2021	BUY	$35.27 - $39.67 $7,300 - $8,211	207 Added 8.37%	2,679 $103,000
Q4 2020 Feb 11, 2021	SELL	$33.15 - $41.97 $17,403 - $22,034	-525 Reduced 17.52%	2,472 $88,000
Q3 2020 Nov 12, 2020	BUY	$34.44 - $42.23 $8,644 - $10,599	251 Added 9.14%	2,997 $114,000
Q2 2020 Jul 31, 2020	SELL	$30.19 - $39.11 $6,188 - $8,017	-205 Reduced 6.95%	2,746 $96,000
Q1 2020 May 05, 2020	BUY	$25.83 - $45.71 $12,889 - $22,809	499 Added 20.35%	2,951 $96,000
Q4 2019 Jan 07, 2020	BUY	$37.87 - $45.37 $24,691 - $29,581	652 Added 36.22%	2,452 $110,000
Q3 2018 Nov 05, 2018	BUY	$32.83 - $38.63 $59,094 - $69,534	1,800 New	1,800 $0
Q3 2018 Nov 05, 2018	SELL	$32.83 - $38.63 $59,094 - $69,534	-1,800 Closed	0 $0
Q2 2018 Aug 07, 2018	BUY	$26.84 - $34.32 $48,312 - $61,776	1,800 New	1,800 $0

Others Institutions Holding BSX

# of Institutions

1,541

Shares Held

1.19B

Call Options Held

6.79M

Put Options Held

10.1M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $130B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Horizon Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Horizon Advisors, Inc. with notifications on news.

Account

First Horizon Advisors, Inc. Boston Scientific Corp Transaction History